StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Abbott Laboratories
NYSE:ABT
Sector
Location
Market Cap
USD 218.92 B
Share Price
USD 125.83
Avg Daily Volume
6,591,886
Change (1 day)
0.08%
Change (1 year)
21.08%
Change (YTD)
11.25%
Abbott Laboratories Accounts Payable for the year ending December 31, 2024: USD 4.20 B
Abbott Laboratories Accounts Payable is USD 4.20 B for the year ending December 31, 2024, a -2.33% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Abbott Laboratories Accounts Payable for the year ending December 31, 2023 was USD 4.29 B, a -6.77% change year over year.
-
Abbott Laboratories Accounts Payable for the year ending December 31, 2022 was USD 4.61 B, a 4.51% change year over year.
-
Abbott Laboratories Accounts Payable for the year ending December 31, 2021 was USD 4.41 B, a 11.71% change year over year.
-
Abbott Laboratories Accounts Payable for the year ending December 31, 2020 was USD 3.95 B, a 21.34% change year over year.
Competitors
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
GE HealthCare Technologies Inc.
USD 77.25
GEHC
+0.76
0.99%
Laboratory Corporation of America Holdings
USD 250.51
LH
-1.56
-0.62%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Globus Medical, Inc.
USD 54.04
GMED
+1.03
1.94%
Indegene Limited
USD 6.47
INDGN.NS
+0.10
1.55%
Raffles Medical Group Ltd
USD 0.82
BSL.SI
-0.00
-0.05%
Guangzhou Wondfo Biotech Co.,Ltd
USD 3.30
300482.SZ
+0.15
4.69%
Nipro Corporation
USD 9.38
8086.T
+0.17
1.79%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Danaher Corporation
USD 197.89
DHR
+7.98
4.20%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
GE HealthCare Technologies Inc.
USD 77.25
GEHC
+0.76
0.99%
Laboratory Corporation of America Holdings
USD 250.51
LH
-1.56
-0.62%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.43
603392.SS
+0.06
0.69%
Globus Medical, Inc.
USD 54.04
GMED
+1.03
1.94%
Indegene Limited
USD 6.47
INDGN.NS
+0.10
1.55%
Raffles Medical Group Ltd
USD 0.82
BSL.SI
-0.00
-0.05%
Guangzhou Wondfo Biotech Co.,Ltd
USD 3.30
300482.SZ
+0.15
4.69%
Nipro Corporation
USD 9.38
8086.T
+0.17
1.79%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Novo Nordisk A/S
USD 69.65
NOVO-B.CO
+3.12
4.69%
Novartis AG
USD 117.27
NOVN.SW
+1.11
0.95%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Thermo Fisher Scientific Inc.
USD 466.71
TMO
+39.09
9.14%
Boston Scientific Corporation
USD 107.76
BSX
+4.60
4.46%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Danaher Corporation
USD 197.89
DHR
+7.98
4.20%